Skip to Content

717 5.4 WATSON (Yohimbine Hydrochloride 5.4 mg)

Pill with imprint 717 5.4 WATSON is , and has been identified as Yohimbine Hydrochloride 5.4 mg. It is supplied by Watson Pharmaceuticals.

Yohimbine is used in the treatment of erectile dysfunction and belongs to the drug class impotence agents. FDA has not classified the drug for risk during pregnancy. Yohimbine 5.4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 717 5.4 WATSON

Yohimbine Hydrochloride

Imprint:
717 5.4 WATSON
Strength:
5.4 mg
Availability:
Prescription only
Drug Class:
Impotence agents
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
National Drug Code (NDC):
52544-0717

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide